The dynamic interplay between AMPK/NFκB signaling and NLRP3 is a new therapeutic target in inflammation: Emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury
2022 · Biomedicine & Pharmacotherapy · 83 citations
https://doi.org/10.1016/j.biopha.2022.112628